119th Congress

H.R. 7970

STOP Nitazenes Act

Introduced
In committee
Passed House
Passed Senate
To President
Became law

Sponsor: Robert E. Latta(R-OH)
Introduced: Mar 18, 2026
Policy area: Crime and Law Enforcement
Committees: House Committee on Energy and Commerce; House Committee on the Judiciary
Official text: Introduced in House · Congress.gov page

Cosponsors (10)

Added later (10)

Eugene Simon Vindman (D-VA) · Mar 26, 2026
David P. Joyce (R-OH) · Mar 27, 2026
Michael Baumgartner (R-WA) · Mar 27, 2026
Tracey Mann (R-KS) · Apr 9, 2026
August Pfluger (R-TX) · Apr 27, 2026
James R. Baird (R-IN) · Apr 27, 2026
Addison P. McDowell (R-NC) · May 13, 2026
Craig A. Goldman (R-TX) · Jun 30, 2026
Tim Moore (R-NC) · Jul 13, 2026
Ken Calvert (R-CA) · Jul 22, 2026

Summary

No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.

Official title: To amend the Controlled Substances Act to permanently schedule 2-benzylbenzimidazole opioids (commonly referred to as nitazenes) as Schedule 1 controlled substances, and for other purposes.

Latest action(Jul 21, 2026): Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 21.

Read the official text

Roll-call votes

No recorded votes on this bill.

Actions

Jul 21, 2026
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 21.
Jul 21, 2026
Committee Consideration and Mark-up Session Held
Jul 20, 2026
Committee Consideration and Mark-up Session Held
Jun 25, 2026
Forwarded by Subcommittee to Full Committee by Voice Vote.
Jun 25, 2026
Subcommittee Consideration and Mark-up Session Held
Mar 18, 2026
Referred to the Subcommittee on Health.
Mar 18, 2026 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 18, 2026
Introduced in House